{"title": "US Biomedical Advanced Research and Development Authority", "author": null, "url": "https://www.pmlive.com/tags/us_biomedical_advanced_research_and_development_authority", "hostname": "pmlive.com", "description": "Latest news and features about US Biomedical Advanced Research and Development Authority - for people working in pharma, biotech and healthcare industries.", "sitename": "PMLive", "date": "2020-04-21", "cleaned_text": "This page shows the latest US Biomedical Advanced Research and Development Authority news and features for those working in and with pharma, biotech and healthcare. In the US, the efficacy rate increased slightly to 72%, while in Latin America and South Africa the vaccine was 66% and 57% effective, respectively. ... Under the terms of the deal, the US Biomedical Advanced Research and Development Authority (BARDA) In the US, the efficacy rate was 72% while in Latin America and South Africa the vaccine was 66% and 57% effective, respectively. ... Under the terms of the deal, the US Biomedical Advanced Research and Development Authority (BARDA) and the US Department US pharma Johnson &Johnson (J&J) is planning to launch its single-dose COVID-19 vaccine in March, according to the company's chief scientific officer Paul Stoffels. ... The phase 3 ENSEMBLE trial was launched in collaboration with the US Department of The phase 3 ENSEMBLE trial is being conducted in collaboration with the US Biomedical Advanced Research and Development Authority (BARDA) and the National Institute of Allergy and Infectious Diseases (NIAID). ... This trial is currently enrolling The pharma giant is initiating the phase 3 ENSEMBLE trial in collaboration with the US Department of Health and Human Services' (HHS), Biomedical Advanced Research and Development Authority (BARDA) and the ... US National Institute of Allergy and A COVID-19 antibody cocktail developed by Regeneron has been given an emergency use authorisation (EUA) from the US Food and Drug Administration (FDA). ... Regeneron has already signed a manufacturing and supply agreement with the US Biomedical Advanced [More from news](//www.pmlive.com/pmlive_search?query=US Biomedical Advanced Research and Development Authority&gscope1=1,6,8||) Approximately 0 fully matching, plus 23 partially matching documents found. So we need long-term strategic investment so that we have therapies and vaccines under development - and the infrastructure to support them, from governments and the private sector - in the vital ... Achaogen and Aradigm filed for bankruptcy in 2019, The phase 1 study, which is being conducted by the US National Institutes of Health (NIH) at Kaiser Permanente Washington Health Research Institute in Seattle, aims to recruit 45 healthy men ... That includes an agreement with the US Biomedical Advanced One of the companies developing pathogen reduction systems for donated blood, Cerus Corporation, signed an agreement in June worth up to $180m with the US Biomedical Advanced Research and Development Authority ... Includes rights to sublicense outside [More from intelligence](//www.pmlive.com/pmlive_search?query=US Biomedical Advanced Research and Development Authority&gscope1=2,3|) Approximately 0 fully matching, plus 3 partially matching documents found. No results were found [ WE'RE ON A MISSION To transform lives through communication that changes behaviour and improves "}